ARCHIVES

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Community-Based Program Final Planning Review In August, October

August 6, 1976

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005